Literature DB >> 19367640

Electrophysiological studies in a mouse model of Schwartz-Jampel syndrome demonstrate muscle fiber hyperactivity of peripheral nerve origin.

Andoni Echaniz-Laguna1, Frédérique Rene, Christophe Marcel, Marie Bangratz, Bertrand Fontaine, Jean-Philippe Loeffler, Sophie Nicole.   

Abstract

Schwartz-Jampel syndrome (SJS) is an autosomal-recessive condition characterized by muscle stiffness and chondrodysplasia. It is due to loss-of-function hypomorphic mutations in the HSPG2 gene that encodes for perlecan, a proteoglycan secreted into the basement membrane. The origin of muscle stiffness in SJS is debated. To resolve this issue, we performed an electrophysiological investigation of an SJS mouse model with a missense mutation in the HSPG2 gene. Compound muscle action potential amplitudes, distal motor latencies, repetitive nerve stimulation tests, and sensory nerve conduction velocities of SJS mice were normal. On electromyography (EMG), neuromyotonic discharges, that is, bursts of motor unit action potentials firing at high rates (120-300 HZ), were constantly observed in SJS mice in all muscles, except in the diaphragm. Neuromyotonic discharges were not influenced by general anesthesia and disappeared with curare administration. They persisted after complete motor nerve section, terminating only with Wallerian degeneration. These results demonstrate that perlecan deficiency in SJS provokes a neuromyotonic syndrome. The findings further suggest a distal axonal localization of the generator of neuromyotonic discharges. SJS should now be considered as an inherited disorder with peripheral nerve hyperexcitability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19367640     DOI: 10.1002/mus.21253

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

Review 1.  Positive muscle phenomena--diagnosis, pathogenesis and associated disorders.

Authors:  Hans G Kortman; Jan H Veldink; Gea Drost
Journal:  Nat Rev Neurol       Date:  2012-01-24       Impact factor: 42.937

Review 2.  The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy.

Authors:  Stephen Douglass; Atul Goyal; Renato V Iozzo
Journal:  Connect Tissue Res       Date:  2015-07-16       Impact factor: 3.417

3.  Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition.

Authors:  Zhuo Xu; Naoki Ichikawa; Keisuke Kosaki; Yoshihiko Yamada; Takako Sasaki; Lynn Y Sakai; Hisashi Kurosawa; Nobutaka Hattori; Eri Arikawa-Hirasawa
Journal:  Matrix Biol       Date:  2010-06-09       Impact factor: 11.583

Review 4.  Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue borders.

Authors:  Mary C Farach-Carson; Curtis R Warren; Daniel A Harrington; Daniel D Carson
Journal:  Matrix Biol       Date:  2013-08-31       Impact factor: 11.583

5.  Alteration of the Neuromuscular Junction and Modifications of Muscle Metabolism in Response to Neuron-Restricted Expression of the CHMP2Bintron5 Mutant in a Mouse Model of ALS-FTD Syndrome.

Authors:  Robin Waegaert; Sylvie Dirrig-Grosch; Haoyi Liu; Marion Boutry; Ping Luan; Jean-Philippe Loeffler; Frédérique René
Journal:  Biomolecules       Date:  2022-03-24

6.  Vascular biomechanical properties in mice with smooth muscle specific deletion of Ndst1.

Authors:  Neeta Adhikari; Marie Billaud; Marjorie Carlson; Spencer P Lake; Kim Ramil C Montaniel; Rod Staggs; Weihua Guan; Dinesha Walek; Snider Desir; Brant E Isakson; Victor H Barocas; Jennifer L Hall
Journal:  Mol Cell Biochem       Date:  2013-10-08       Impact factor: 3.396

7.  A mouse model of Schwartz-Jampel syndrome reveals myelinating Schwann cell dysfunction with persistent axonal depolarization in vitro and distal peripheral nerve hyperexcitability when perlecan is lacking.

Authors:  Marie Bangratz; Nadège Sarrazin; Jérôme Devaux; Désirée Zambroni; Andoni Echaniz-Laguna; Frédérique René; Delphine Boërio; Claire-Sophie Davoine; Bertrand Fontaine; Maria Laura Feltri; Evelyne Benoit; Sophie Nicole
Journal:  Am J Pathol       Date:  2012-03-23       Impact factor: 4.307

8.  Perlecan Facilitates Neuronal Nitric Oxide Synthase Delocalization in Denervation-Induced Muscle Atrophy.

Authors:  Satoshi Nakada; Yuri Yamashita; Shuichi Machida; Yuko Miyagoe-Suzuki; Eri Arikawa-Hirasawa
Journal:  Cells       Date:  2020-11-23       Impact factor: 6.600

9.  Squalenoyl siRNA PMP22 nanoparticles are effective in treating mouse models of Charcot-Marie-Tooth disease type 1 A.

Authors:  Suzan Boutary; Marie Caillaud; Mévidette El Madani; Jean-Michel Vallat; Julien Loisel-Duwattez; Alice Rouyer; Laurence Richard; Céline Gracia; Giorgia Urbinati; Didier Desmaële; Andoni Echaniz-Laguna; David Adams; Patrick Couvreur; Michael Schumacher; Charbel Massaad; Liliane Massaad-Massade
Journal:  Commun Biol       Date:  2021-03-09

Review 10.  Perlecan, A Multi-Functional, Cell-Instructive, Matrix-Stabilizing Proteoglycan With Roles in Tissue Development Has Relevance to Connective Tissue Repair and Regeneration.

Authors:  Anthony J Hayes; Brooke L Farrugia; Ifechukwude J Biose; Gregory J Bix; James Melrose
Journal:  Front Cell Dev Biol       Date:  2022-04-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.